Delivery Order SPE2DE24DA017-SPE2D625F3ZFX
- Not listed
- Arthrex Inc., a leading provider of minimally invasive orthopedic medical technologies based in Naples, Florida, was awarded a delivery order valued at $3,394.38 on August 20, 2025, for a Nanoneedle Scope measuring 125mm. This fixed-price contract with economic price adjustment is scheduled for completion by September 4, 2025, and will be performed at Arthrex's facility in Naples, Florida. The award was issued by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order on August 19, 2025, for a Nanoneedle Scope measuring 125mm. This fixed-price contract with economic price adjustment carries a ceiling value of $1,732.50 and is scheduled for completion by September 3, 2025. The contract represents a delivery order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies based in Naples, Florida, was awarded a delivery order valued at $3,521.10 for a Nanoneedle Scope (125mm) by the Defense Logistics Agency's Medical Supply Chain on August 28, 2025. This fixed-price delivery order with economic price adjustment is scheduled for completion by September 12, 2025, with performance taking place in Naples, Florida. The contract was awarded without a set-aside designation, reflecting...
- Arthrex Inc., a leading provider of minimally invasive orthopedic medical technologies based in Naples, Florida, received a delivery order award from the Defense Logistics Agency's Medical Supply Chain for a Nanoneedle Scope measuring 125mm, with a ceiling value of $2,310.00. The contract, issued on September 12, 2025, is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of September 26, 2025. This award was not set aside...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $1,155.00 to Arthrex Inc. for a Nanoneedle Scope, 125mm. This fixed-price contract with economic price adjustment provisions is scheduled for completion by September 19, 2025, with performance taking place at Arthrex's headquarters in Naples, Florida. The award carries no set-aside designation, reflecting Arthrex's strong competitive position in the federal orthopedic medical device marketplace....
- The U.S. Department of Defense Medical Supply Chain awarded Arthrex Inc. a delivery order valued at $4,042.50 for a 125mm Nanoneedle Scope on July 31, 2025, with an ultimate completion date of August 14, 2025. This fixed-price contract with economic price adjustment provisions was issued without a set-aside designation, reflecting Arthrex's strong competitive standing in the federal orthopedic medical device marketplace. The work will be performed at the contractor's Naples, Florida facility,...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $1,298.22 to Arthrex Inc. for a Nanoneedle Scope, 125mm, with an ultimate completion date of September 25, 2025. This fixed-price contract with economic price adjustment will be fulfilled at Arthrex's Naples, Florida location. The award represents a task order under Arthrex's existing Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense Logistics Agency, a comprehensive $471 million...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies, received a delivery order valued at $1,067.22 for a Nanoneedle Scope (125mm) from the Defense Logistics Agency's Medical Supply Chain on July 14, 2025. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of August 7, 2025, and will be performed in Naples, Florida. The award represents an order against Arthrex's existing Indefinite Delivery Contract (SPE2DE24D0020)...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $1,267.20 on June 18, 2025, for a Nanoneedle Diagnostic Sheath Kit (125mm) under a fixed-price contract with economic price adjustment provisions. The order, which must be completed by July 3, 2025, carries no set-aside designation, reflecting Arthrex's competitive standing in the federal market. This delivery order is issued under Arthrex's larger Indefinite...
- This delivery order, valued at $1,573.44, was awarded to Arthrex Inc. on August 21, 2025, for the supply of a Nanoneedle Scope measuring 125mm. The contract, which operates under a fixed-price structure with economic price adjustment provisions, is scheduled for completion by September 5, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal entity responsible for procuring medical supplies for military and veteran healthcare systems. No...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F3ZFXDelivery Order
Arthrex Inc., a leading minimally invasive orthopedic medical technology company headquartered in Naples, Florida, received a delivery order award for a Nanoneedle Scope (125mm) with a ceiling value of $2,310.00. This fixed-price contract with economic price adjustment was awarded on September 22, 2025, with an ultimate completion date of October 6, 2025. The contract is being funded through the Defense Logistics Agency's Medical Supply Chain, a defense agency component, with performance taking place at Arthrex's Naples, Florida facility. This delivery order was issued under Arthrex's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (SPE2DE24D0020), a comprehensive single-award vehicle valued at $471 million and running through September 2029 that enables Veterans Affairs medical centers nationwide to access Arthrex's orthopedic product portfolio. The nanoneedle scope represents a specialized surgical instrument consistent with Arthrex's broader product offerings of advanced orthopedic surgical tools and arthroscopic instruments. No set-aside designation was used for this award, reflecting Arthrex's strong competitive position in the federal orthopedic medical device marketplace. The company has demonstrated substantial capability in supporting government healthcare systems, having already received over $550,000 in delivery orders under the existing IDC since its inception in June 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/22/25 |